Clinical trial / 2017
Resveratrol supplementation for 14 weeks improved cerebrovascular responsiveness and cognitive performance in post-menopausal women.
Eighty post-menopausal women aged 45-85 years were randomized to take trans-resveratrol or placebo for 14 weeks. Compared to placebo, resveratrol led to 17% increases in cerebrovascular responsiveness (CVR) to both hypercapnic (p = 0.010) and cognitive stimuli (p = 0.002). Resveratrol significantly improved performance in verbal memory tasks (p = 0.041) and overall cognitive performance (p = 0.020), which correlated with the increase in CVR (r = 0.327; p = 0.048). Mood tended to improve across multiple measures, but the changes were not statistically significant.
- Study type
- Randomized placebo-controlled trial
- Who was studied
- 80 post-menopausal women aged 45-85 years
- What was measured
- Cognitive performance, cerebral blood flow velocity, pulsatility index, cerebrovascular responsiveness (CVR), and mood
THE PAPER
Effects of Resveratrol on Cognitive Performance, Mood and Cerebrovascular Function in Post-Menopausal Women; A 14-Week Randomised Placebo-Controlled Intervention Trial.
Evans HM, Howe PR, Wong RH. Nutrients, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.